A new member of the Olink family joins us in Singapore!
We are delighted to introduce Dr. Wen Jing Sim, who will represent Olink Proteomics as our first Business Development Manager in Asia. Wen Jing will be based in Singapore, and support new and existing customers based in a broad region including Japan, South Korea, Australia/New Zealand, as well as Singapore itself.
Who is Wen Jing Sim?
Wen attained her PhD in biological sciences, majoring in oncology, from the National University of Singapore. She subsequently gained experience working with multi-omics patient stratification, high throughput drug screening, immuno-oncology and development of innovative cancer diagnostics platform
In her own words..
“I truly believe in the value of precision medicine for disease management and healthcare, as well as the teamwork that is required to move precision medicine forward. I am excited to be part of an innovative company that shares the same vision and goals. Olink’s dedication and determination in developing technology and products that help researchers and clinicians both in academia and industry to advance in precision medicine is explicitly showcased through its thoroughly validated, high throughput panels and their transparency in validation data.
Olink also puts strong emphasis on scientific discussion and post-analysis service ,which allows me to bring the skills and knowledge I developed as a scientific researcher into great use. This also gives me the opportunity to embark on the journey towards precision medicine with our researchers and clinicians.”